glp 1 agonist shortage The GLP-1 boom created one of the strangest health stories of the decade. Drugs built for diabetes and obesity became pop-culture products, then supply shortages opened the door to falsified versions. WHO GLP-1 Receptor Agonist Market Growth

Shortages and expiry date of medicines and stringent regulatory requirements are key limiting factors driving the market

Weve mapped out safe, legitimate strategies to lower your costs in our guide to the cheapest way to get GLP-1 medications

These medications have undergone extensive clinical trials to evaluate their efficacy and safety in managing type 2 diabetes and, more recently, their potential for weight loss

BL, baseline

Identifying the Strong Response Endotype For the study, researchers conducted a secondary analysis of data from a previous clinical trial of tirzepatide in patients with OSA and obesity

This weight reduction not only improves physical health but also positively impacts mental well-being and self-esteem